pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
ibudilast
ibudilast [INN]
Amyotrophic Lateral Sclerosis
$MNOV
MEDICINOVA INC
Marketed
ibuprofen lysine
Neoprofen (ibuprofen lysine)
Patent Ductus Arteriosus
Recordati Rare Diseases Inc
Phase 3
ibutamoren mesylate
Oratrope (ibutamoren mesylate)
Growth Hormone Deficiency
Lumos Pharma Inc
← prev
page 185 of 231
next →
Pain
89
Neurology
1
Marketed
ibutilide fumarate
Ibutilide Fumarate
Atrial Fibrillation
American Regent Inc
Phase 3
ibuzatrelvir
ibuzatrelvir
Coronavirus Disease 2019 (COVID-19)
$PFE
PFIZER INC
Marketed
icatibant acetate
Firazyr (icatibant acetate)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
Takeda Pharmaceuticals USA Inc
Marketed
icosapent ethyl
Alfa (icosapent ethyl)
Familial Adenomatous Polyposis
KD Pharma Group SA
Phase 2
icovamenib
icovamenib
Type 2 Diabetes
$BMEA
Biomea Fusion, Inc.
Marketed
idarucizumab
Praxbind (idarucizumab)
Bleeding And Clotting Disorders
Boehringer Ingelheim Corp
Marketed
idecabtagene vicleucel
Abecma (idecabtagene vicleucel)
Refractory Multiple Myeloma
Celgene Corp
Phase 2
idroxioleic acid
idroxioleic acid
Malignant Glioma
Laminar Pharmaceuticals SA
Marketed
idursulfase
Elaprase (idursulfase)
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Shire Human Genetic Therapies Inc
Phase 2
ifenprodil
ifenprodil [INN]
Chronic Cough
Seyltx Inc
Phase 2
ifetroban
Dyscorban (ifetroban)
Duchenne Muscular Dystrophy
$CPIX
CUMBERLAND PHARMACEUTICALS INC
Phase 2
ifezuntirgene inilparvovec
ifezuntirgene inilparvovec [INN]
Huntington Disease
UniQure NV
pre_registration
ifinatamab deruxtecan
ifinatamab deruxtecan
Small-Cell Lung Cancer
Daiichi Sankyo Co Ltd
Phase 2
ignaseclant
ignaseclant
Myasthenia Gravis
NMD Pharma AS
Marketed
iloperidone
Fanapt (iloperidone)
Bipolar I Disorder
$VNDA
Vanda Pharmaceuticals Inc.
Phase 3
iltamiocel
iltamiocel
Stress Urinary Incontinence
Cook MyoSite Inc
Phase 2
imapextide sodium LA
imapextide sodium
Hypoglycemia
$MBX
MBX Biosciences, Inc.
Phase 2
imdusiran sodium
imdusiran sodium
Hepatitis B
$ABUS
Arbutus Biopharma Corp
Phase 2
imeglimin
imeglimin [INN]
Type 2 Diabetes
Poxel SA
Phase 3
imeroprubart
imeroprubart
Rheumatoid Arthritis
$IMVT
Immunovant, Inc.
Phase 2
imifoplatin
imifoplatin
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Promontory Therapeutics Inc
Marketed
imipramine
Imipramine Hydrochloride (imipramine [INN])
Enuresis
Oxford Pharmaceuticals LLC
pre_registration
imlifidase
Idefirix (imlifidase)
Kidney Transplant Rejection
Hansa Biopharma AB
Phase 2
imneskibart
imneskibart
Colorectal Cancer
Aulos Bioscience Inc
pre_registration
imsidolimab
imsidolimab
Generalized Pustular Psoriasis (GPP)
$VNDA
Vanda Pharmaceuticals Inc.
Phase 2
imzokitug
imzokitug
Colorectal Cancer
Bristol-Myers Squibb Co
Marketed
inamrinone
Amrinone Lactate (inamrinone)
Congestive Heart Failure (Heart Failure)
Hikma Pharmaceuticals USA Inc